Darwin Wealth Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$622 Hold
25
﹤0.01% 587
2026
Q1
$350 Hold
25
﹤0.01% 566
2025
Q4
$280 Hold
25
﹤0.01% 609
2025
Q3
$289 Hold
25
﹤0.01% 573
2025
Q2
$306 Hold
25
﹤0.01% 569
2025
Q1
$398 Hold
25
﹤0.01% 592
2024
Q4
$398 Hold
25
﹤0.01% 592
2024
Q3
$601 Buy
+25
New +$571 ﹤0.01% 587
2020
Q2
Sell
-25
Closed 199
2020
Q1
$0 Buy
+25
New +$747 ﹤0.01% 789

Other funds holding AVNS

Darwin Wealth Management's AVNS Position: Q2 2026 in Review

Darwin Wealth Management held its Avanos Medical (AVNS) position steady in Q2 2026 at 25 shares worth $622. The position accounts for ﹤0.01% of the portfolio, ranked #587.

Darwin Wealth Management first reported a position in AVNS in Q1 2020 and has held it in 9 quarters since. 73 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Darwin Wealth Management held 25 shares of Avanos Medical worth $622 as of Q2 2026.
  • Darwin Wealth Management left its Avanos Medical share count unchanged in Q2 2026.
  • Avanos Medical made up ﹤0.01% of Darwin Wealth Management's portfolio in Q2 2026, its #587 holding.
  • Darwin Wealth Management first reported a position in Avanos Medical in Q1 2020 and has held it in 9 quarters since.
  • 73 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Darwin Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.